Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Sells 5,000 Shares

Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, sold 5,000 shares of common stock on June 4, 2024, at a weighted average price of $63.58.

Summary

• On June 4, 2024, Stephen P. Carey, the SVP & CFO of ANI Pharmaceuticals, sold 5,000 shares of the company's common stock.
• The sale was executed at a weighted average price of $63.58 per share.
• Following the transaction, Carey directly owns 161,968 shares of ANI Pharmaceuticals.
• The shares were sold in multiple trades at prices ranging from $62.72 to $64.85.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an insider stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine disclosure of an insider transaction. It's common for executives to periodically sell shares for personal financial management.

Stakeholder Impact

• The sale of shares by a high-ranking executive could be perceived negatively by some investors, potentially leading to minor short-term price fluctuations.

Key Dates